Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Profound Medical Corp. Common Stock (PROF)

https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/09/2016

Market Cap

232,332,282

Shares Outstanding

21,260,000

Weighted SO

24,032,400

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

SIBN --.--%

SGHT --.--%

NVRO --.--%

FNA --.--%

LUNG --.--%

IRMD --.--%

OFIX --.--%

NPCE --.--%

ITGR --.--%

Beta

0.8320

Last Div

0.0000

Range

7.11-11.69

Chg

0.0200

Avg Vol

33232

Mkt Cap

232332282

Exch

NASDAQ

Country

CA

Phone

16474761350

DCF Diff

17.8821

DCF

-8.4121

Div Yield

0.0000

P/S

29.3107

EV Multiple

-6.9040

P/FV

5.9118

Div Yield %

0.0000

P/E

-8.3407

PEG

-0.4530

Payout

0.0000

Current Ratio

8.6143

Quick Ratio

7.4184

Cash Ratio

6.0542

DSO

329.7465

DIO

798.3872

Op Cycle

1128.1337

DPO

316.7695

CCC

811.3642

Gross Margin

0.6118

Op Margin

-3.8938

Pretax Margin

-3.5282

Net Margin

-3.5082

Eff Tax Rate

0.0057

ROA

-0.5559

ROE

-0.7194

ROCE

-0.6952

NI/EBT

0.9943

EBT/EBIT

0.9061

EBIT/Rev

-3.8938

Debt Ratio

0.1244

D/E

0.1586

LT Debt/Cap

0.0913

Total Debt/Cap

0.1369

Int Coverage

-35.1979

CF/Debt

-3.6844

Equity Multi

1.2751

Rec Turnover

1.1069

Pay Turnover

1.1523

Inv Turnover

0.4572

FA Turnover

6.7874

Asset Turnover

0.1585

OCF/Share

-0.9383

FCF/Share

-0.9383

Cash/Share

1.3942

OCF/Sales

-2.8931

FCF/OCF

1.0000

CF Coverage

-3.6844

ST Coverage

-10.0506

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

5.9118

P/B

5.9118

P/S

29.3107

P/E

-8.3407

P/FCF

-10.1314

P/OCF

-10.1142

P/CF

-10.1142

PEG

-0.4530

P/S

29.3107

EV Multiple

-6.9040

P/FV

5.9118

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Mar 27, 01:59 Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws GlobeNewswire Inc. Dec 05, 21:48 Profound Medical Announces Proposed Public Offering of Common Shares GlobeNewswire Inc. Jan 16, 16:30 Profound Medical Announces Non-Brokered Private Placement GlobeNewswire Inc. Jan 03, 16:15 Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues GlobeNewswire Inc. Dec 27, 22:40 Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares GlobeNewswire Inc. Dec 27, 22:40 Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares GlobeNewswire Inc. Dec 27, 22:40 Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares GlobeNewswire Inc. Dec 27, 22:40 Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares GlobeNewswire Inc. Dec 27, 22:40 Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares GlobeNewswire Inc. Dec 27, 22:40 Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares GlobeNewswire Inc. Dec 27, 16:15 Profound Medical Announces Proposed Public Offering of Common Shares GlobeNewswire Inc. Dec 27, 16:15 Profound Medical Announces Proposed Public Offering of Common Shares GlobeNewswire Inc. Nov 08, 07:45 Profound Medical to Participate in the Stifel 2023 Healthcare Conference

Revenue Product Segmentation